Are digital therapeutics (DTx) the future of mental health care?
Originally presented at the DTx West 2021 Conference on February 25th 2021.
Join Big Health’s Dr. Jenna Carl, VP of Clinical Development and Medical Affairs as she moderates a panel discussion with Dr. Andrew Krystal of UCSF, Dr. Juliette McClendon from Boston University, Dr. Jordan Silberman from Anthem, and Brian Dolan from Exits and Outcomes, on the importance of clinical evidence to the future of digital therapeutics.
Don’t have time to watch the full video? We got your back. Check out our blog highlighting the key takeaways from the panel.
Here’s our latest
Tearing Down Barriers to Mental Health Care: A Presentation with Target
Target & Big Health talk mental health strategy: what will increasing access look like in 2020 and beyond? Employees often…
A Patient-First Perspective on Digital Therapeutics: A Presentation from DTx West
Two employees speak about the life-changing experience of using Sleepio and Daylight, digital therapeutics for poor sleep and worry and…
Spotlight on mental health equity: A conversation from the Behavioral Health Tech Conference
Join Big Health’s conversation with Delta Air Lines at Business Group on Health’s 2021 Annual Conference as we explore mental…